At Sayre Therapeutics, we focus on bringing hitherto unavailable novel medicines, drug-delivery devices, companion diagnostics and diagnostic imaging agents to medical oncologists, surgical oncologists, radiation oncologists, interventional radiologists and rheumatologists.These include, but are not limited to, small molecules, recombinant proteins,monoclonal antibodies (mAbs),drug-delivery devices and diagnostics in Oncology and Immunology.Our business model encompasses Global access / early access programs, Named Patient programs and securing product registrations for exclusive commercial distribution in South Asia.
View Top Employees from Sayre TherapeuticsWebsite | http://www.sayretherapeutics.com/ |
Revenue | $5 million |
Funding | $9 million |
Employees | 39 (39 on RocketReach) |
Founded | 2015 |
Address | Inner Ring Rd, Domlur, Karnataka 560071, IN |
Phone | +91 80 4866 6604 |
Technologies |
JavaScript,
HTML,
PHP
+20 more
(view full list)
|
Industry | Biotechnology Research, Manufacturing General, Biotechnology, Manufacturing, Science and Engineering, Health Diagnostics, Health Care, Medical Device, Therapeutics |
Competitors | Finoso Pharma Pvt Ltd., Gland Pharma Limited, MSN Laboratories, Neuland Ireland, Pharma Company |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies |
Looking for a particular Sayre Therapeutics employee's phone or email?
The Sayre Therapeutics annual revenue was $5 million in 2024.
Shukrit Chimote is the CEO of Sayre Therapeutics.
39 people are employed at Sayre Therapeutics.
Sayre Therapeutics is based in Domlur, Karnataka.
The NAICS codes for Sayre Therapeutics are [32, 32541, 3254, 325].
The SIC codes for Sayre Therapeutics are [283, 28].